Eli Lilly earmarks $1B to boost India manufacturing footprintnews2025-10-07T12:59:35+00:00October 7th, 2025|Endpoints News|
FDA launches pilot program to improve US generic drug manufacturingnews2025-10-06T15:43:57+00:00October 6th, 2025|Endpoints News|
Cell therapy CDMO Mytos unveils its first facility in the UK news2025-10-06T12:00:45+00:00October 6th, 2025|Endpoints News|
Cidara receives BARDA award worth up to $339M for candidate that prevents flunews2025-10-03T11:06:08+00:00October 3rd, 2025|Endpoints News|
Groups accuse drugmakers of conspiring to pressure UK over drug pricesnews2025-10-02T16:43:51+00:00October 2nd, 2025|Endpoints News|
Hans Scientific invests $2B in US to avoid tariffs; Thermo Fisher inks up to $1B contractnews2025-10-02T15:28:42+00:00October 2nd, 2025|Endpoints News|
Trump’s 100% pharma tariff won’t start Oct. 1, White House confirmsnews2025-10-01T18:04:52+00:00October 1st, 2025|Endpoints News|
Ansa Biotechnologies closes $54.4M Series B to boost US DNA manufacturing news2025-10-01T12:00:10+00:00October 1st, 2025|Endpoints News|
White House confirms Section 232 pharma investigation has resulted in 100% tariffs on some brand drugsnews2025-09-30T13:55:36+00:00September 30th, 2025|Endpoints News|
Trump’s new tariff threat throws months of deals and negotiations into uncertainty news2025-09-26T16:01:06+00:00September 26th, 2025|Endpoints News|
